Stepwise progression of invasive mucinous adenocarcinoma based on radiological and biological characteristics. 2023

Eisuke Goto, and Kazuya Takamochi, and Satsuki Kishikawa, and Takuo Hayashi, and Takuya Ueda, and Aritoshi Hattori, and Mariko Fukui, and Takeshi Matsunaga, and Kenji Suzuki, and
Department of General Thoracic Surgery, Juntendo University School of Medicine, Japan.

Invasive mucinous lung adenocarcinoma (IMA) has unique radiological findings and pathological characteristics. IMA is classified into solitary and pneumonic types; however, it is unclear whether these are biologically identical. A single-center retrospective analysis was performed for 70 IMA patients (solitary type [n = 38] and pneumonic type [n = 32]) who underwent pulmonary resection between January 2010 and December 2018. We compared clinical and biological characteristics between the two types. The frequencies of genetic alternations such as EGFR, KRAS, BRAF, GNAS, ERBB2, TP53, NRG1, and MET were not different. Immunohistochemically, expression of MUC1 was significantly more common in the pneumonic type (5.0% versus 20.0%, p = 0.01) and diffuse MUC6 positive in the solitary type (39.0% versus 13.0%, p = 0.02). We further classified solitary types into those with or without ground-glass opacity (GGO) and pneumonic types into those with or without crazy-paving appearance (CPA), and evaluated their surgical outcomes. Five-year overall survival and relapse free survival rates were 95.8%/86.6%, 64.3%/70.7%, 74.6%/68.9%, and 50.0%/28.6% in patients with solitary type with GGO, solitary type without GGO, pneumonic type without CPA, and pneumonic type with CPA, respectively. There were no differences in genetic alternations; however, mucin expression pattern was different. Surgical outcomes were different according to the presence of GGO in the solitary type and the presence of CPA in the pneumonic type. These findings suggested a stepwise progression from solitary to pneumonic IMA.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D009077 Mucins High molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface. Mucin
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077192 Adenocarcinoma of Lung A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer. Lung Adenocarcinoma,Adenocarcinoma, Lung,Adenocarcinomas, Lung,Lung Adenocarcinomas
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Eisuke Goto, and Kazuya Takamochi, and Satsuki Kishikawa, and Takuo Hayashi, and Takuya Ueda, and Aritoshi Hattori, and Mariko Fukui, and Takeshi Matsunaga, and Kenji Suzuki, and
October 2019, Lung cancer (Amsterdam, Netherlands),
Eisuke Goto, and Kazuya Takamochi, and Satsuki Kishikawa, and Takuo Hayashi, and Takuya Ueda, and Aritoshi Hattori, and Mariko Fukui, and Takeshi Matsunaga, and Kenji Suzuki, and
May 2008, Lung cancer (Amsterdam, Netherlands),
Eisuke Goto, and Kazuya Takamochi, and Satsuki Kishikawa, and Takuo Hayashi, and Takuya Ueda, and Aritoshi Hattori, and Mariko Fukui, and Takeshi Matsunaga, and Kenji Suzuki, and
January 2022, Interactive cardiovascular and thoracic surgery,
Eisuke Goto, and Kazuya Takamochi, and Satsuki Kishikawa, and Takuo Hayashi, and Takuya Ueda, and Aritoshi Hattori, and Mariko Fukui, and Takeshi Matsunaga, and Kenji Suzuki, and
March 2024, The clinical respiratory journal,
Eisuke Goto, and Kazuya Takamochi, and Satsuki Kishikawa, and Takuo Hayashi, and Takuya Ueda, and Aritoshi Hattori, and Mariko Fukui, and Takeshi Matsunaga, and Kenji Suzuki, and
January 2023, BMC pulmonary medicine,
Eisuke Goto, and Kazuya Takamochi, and Satsuki Kishikawa, and Takuo Hayashi, and Takuya Ueda, and Aritoshi Hattori, and Mariko Fukui, and Takeshi Matsunaga, and Kenji Suzuki, and
January 2024, Histopathology,
Eisuke Goto, and Kazuya Takamochi, and Satsuki Kishikawa, and Takuo Hayashi, and Takuya Ueda, and Aritoshi Hattori, and Mariko Fukui, and Takeshi Matsunaga, and Kenji Suzuki, and
August 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
Eisuke Goto, and Kazuya Takamochi, and Satsuki Kishikawa, and Takuo Hayashi, and Takuya Ueda, and Aritoshi Hattori, and Mariko Fukui, and Takeshi Matsunaga, and Kenji Suzuki, and
November 2023, International journal of surgical pathology,
Eisuke Goto, and Kazuya Takamochi, and Satsuki Kishikawa, and Takuo Hayashi, and Takuya Ueda, and Aritoshi Hattori, and Mariko Fukui, and Takeshi Matsunaga, and Kenji Suzuki, and
August 2016, Journal of cancer research and clinical oncology,
Eisuke Goto, and Kazuya Takamochi, and Satsuki Kishikawa, and Takuo Hayashi, and Takuya Ueda, and Aritoshi Hattori, and Mariko Fukui, and Takeshi Matsunaga, and Kenji Suzuki, and
December 2019, Translational cancer research,
Copied contents to your clipboard!